AVITA Medical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
AVITA Medical, Inc. (RCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 1.10 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2026-02-12
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-06-30 was 500.00 shares, a 58.33% decline year-over-year.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-03-31 was 600.00 shares, a 97.13% decline year-over-year.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2025 was 1.10K shares, a 95.53% decline from fiscal 2024.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2024 was 24.60K shares, a 48.87% decline from fiscal 2023.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 48.13K shares, a 46.05% decline from fiscal 2022.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 89.21K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-12 | 500.00 shares derived: sum of 3 quarters · filed 2026-02-12 | 1.10K shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 500.00 shares derived: sum of 2 quarters · filed 2025-11-06 | 1.10K shares 10-Q · filed 2025-11-06 | 1.60K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 500.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 1.10K shares 10-Q · filed 2025-08-08 | 1.60K shares derived: sum of 3 quarters · filed 2025-08-08 | 3.60K shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | 600.00 shares 10-Q · filed 2025-05-08 | 1.10K shares derived: sum of 2 quarters · filed 2025-05-08 | 3.10K shares derived: sum of 3 quarters · filed 2025-05-08 | 4.30K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 500.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 2.50K shares derived: sum of 2 quarters · filed 2025-02-13 | 3.70K shares derived: sum of 3 quarters · filed 2025-02-13 | 24.60K shares 10-K · filed 2025-02-13 |
| 2024-09-30 | 2.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 3.20K shares derived: sum of 2 quarters · filed 2024-11-07 | 24.10K shares 10-Q · filed 2024-11-07 | 24.69K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 1.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 22.10K shares 10-Q · filed 2024-08-08 | 22.69K shares derived: sum of 3 quarters · filed 2024-08-08 | 23.10K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 20.90K shares 10-Q · filed 2024-05-13 | 21.49K shares derived: sum of 2 quarters · filed 2024-05-13 | 21.90K shares derived: sum of 3 quarters · filed 2024-05-13 | 67.53K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 589.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 1.00K shares derived: sum of 2 quarters · filed 2024-02-22 | 46.63K shares derived: sum of 3 quarters · filed 2024-02-22 | 48.13K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 411.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 46.04K shares derived: sum of 2 quarters · filed 2023-11-09 | 47.54K shares 10-Q · filed 2023-11-09 | 71.34K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 45.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 47.13K shares 10-Q · filed 2023-08-10 | 70.92K shares derived: sum of 3 quarters · filed 2023-08-10 | 131.99K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 1.50K shares 10-Q · filed 2023-05-11 | 25.30K shares derived: sum of 2 quarters · filed 2023-05-11 | 86.36K shares derived: sum of 3 quarters · filed 2023-05-11 | |
| 2022-12-31 | 23.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 84.86K shares derived: sum of 2 quarters · filed 2023-02-23 | 89.21K shares 10-K · filed 2023-02-23 | |
| 2022-09-30 | 61.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 65.41K shares 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | 4.35K shares 10-Q · filed 2022-08-11 | |||
| 2021-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-26 | 0.00 shares derived: sum of 2 quarters · filed 2021-08-26 | 45.00K shares derived: sum of 3 quarters · filed 2021-08-26 | 45.00K shares 10-K · filed 2021-08-26 |
| 2021-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | 45.00K shares derived: sum of 2 quarters · filed 2021-05-13 | 45.00K shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 45.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | 45.00K shares 10-Q · filed 2021-02-16 | ||
| 2020-09-30 | 2.00 shares 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | 0.00 shares 10-K · filed 2020-08-27 |